Helping Men Restore Vitality, Confidence, and Wellbeing
BIOV8 HAS HELPED THOUSANDS OF PEOPLE ON THEIR JOURNEY TO A HEALTHIER AND HAPPIER LIFE
JOIN OUR WAITLIST
At BIOV8, we offer a clinical approach to hormone health for men experiencing symptoms related to low testosterone levels.
Sexual Function and Libido
Mood and Cognitive Function
Bone Density and Muscle Mass
Metabolic Health
Made in Australian compounded pharmacies
100% online & delivered to you
Australia's leading longevity medical clinicians
Common symptoms of low testosterone in men
Begin your journey to optimal health
Our hormone therapy service is patient-first and overseen by registered Australian practitioners. Here’s what to expect:

Check your eligibility

Pathology Testing

Doctor Review & Treatment Plan

Free Delivery & Ongoing Support
Frequently asked questions
Is hormone therapy right for You?
What is hormone therapy?
Hormone therapy is a treatment prescribed to men who have clinically diagnosed low testosterone levels (also known as hypogonadism). It aims to restore testosterone to normal levels to support physical, mental, and emotional wellbeing. ormone therapy is only offered following proper diagnosis and medical assessment.
What are the symptoms of low testosterone?
- Fatigue or reduced energy
- Decreased libido or sexual performance
- Difficulty with focus or memory
- Mood changes such as irritability or low motivation
- Loss of muscle mass or increased body fat
How is low testosterone diagnosed?
Low testosterone is diagnosed through a combination of symptom assessment and pathology testing (blood tests). Blood is usually taken in the morning to ensure accurate hormone level readings.
Do I need a referral?
No referral is needed. You can book directly with a BIOV8 doctor through our platform for an initial telehealth consultation.
Is hormone therapy safe?
All medical treatments carry risks and benefits. Hormone therapy is only prescribed if it's considered safe and appropriate for your individual health needs. Ongoing monitoring through follow-up appointments and pathology testing is an essential part of any TRT program.
What types of testosterone treatment are available?
Treatment options may include topical gels, injections, or other forms — but the most appropriate option will depend on your specific needs and doctor’s recommendation. BIOV8 does not promote or advertise specific products; all treatments are discussed as part of a private consultation with your doctor.
Can I get hormone therapy without testing?
No. Hormone therapy is only prescribed after a confirmed diagnosis of testosterone deficiency through clinical evaluation and blood tests. This ensures treatment is safe, legal, and medically appropriate.
Can I stop treatment at any time?
Yes, but it’s important to discuss this with your doctor. Stopping hormone therapy suddenly without medical supervision may lead to unwanted side effects. Your doctor will help you transition safely if needed.
What risks & considerations should I be aware of?
While hormone therapy offers numerous benefits, it is essential to consider potential risks and individual patient factors:
- Prostate Health: Concerns have been raised regarding hormone therapy's impact on prostate health. However, current evidence does not conclusively link hormone therapy to an increased risk of prostate cancer.
- Cardiovascular Risks: The effect of hormone therapy on cardiovascular health remains a topic of ongoing research, with studies yielding mixed results. Clinicians should evaluate individual risk factors when considering hormone therapy.
- Individualised Treatment: hormone therapy should be tailored to each patient's unique clinical profile, with regular monitoring to assess efficacy and detect potential adverse effects.
- Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., & Montori, V.M. (2010). Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. The Journal of Clinical Endocrinology & Metabolism, 95(6), 2536-2559. https://doi.org/10.1210/jc.2009-2354
- Xu, Z., Chen, X., Zhou, H., Ren, C., Wang, Q., Pan, Y., Liu, L., & Liu, X. (2024). An updated systematic review and meta-analysis of the effects of testosterone replacement therapy on erectile function and prostate. Frontiers in Endocrinology, 15, Article 1335146. https://doi.org/10.3389/fendo.2024.1335146
- Morgentaler, A., Miner, M.M., Caliber, M., Guay, A.T., Khera, M., Traish, A.M., & Zitzmann, M. (2015). Testosterone therapy and cardiovascular risk: advances and controversies. Mayo Clinic Proceedings, 90(2), 224-251. https://doi.org/10.1016/j.mayocp.2014.10.011
- Snyder, P.J., Bhasin, S., Cunningham, G.R., Matsumoto, A.M., Stephens-Shields, A.J., Cauley, J.A., Gill, T.M., Barrett-Connor, E., Swerdloff, R.S., Wang, C., & Ensrud, K.E. (2016). Effects of testosterone treatment in older men. The New England Journal of Medicine, 374(7), 611-624. https://doi.org/10.1056/NEJMoa1506119
- Corona, G., Maseroli, E., Rastrelli, G., & Maggi, M. (2014). Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis. Expert Opinion on Drug Safety, 13(10), 1327-1351. https://doi.org/10.1517/14740338.2014.950653
- Bassil, N., Alkaade, S., & Morley, J.E. (2009). The benefits and risks of testosterone replacement therapy: a review. Therapeutics and Clinical Risk Management, 5, 427-448. https://doi.org/10.2147/tcrm.s3025
- Huo, S., Scialli, A.R., McGarvey, S., Hill, E., & Cooke, P.S. (2016). Treatment of men for “low testosterone”: a systematic review. PLoS ONE, 11(9), e0162480. https://doi.org/10.1371/journal.pone.0162480
- Finkle, W.D., Greenland, S., Ridgeway, G.K., Adams, J.L., Frasco, M.A., Cook, M.B., Fraumeni, J.F., & Hoover, R.N. (2014). Increased risk of non-fatal myocardial infarction following testosterone therapy prescription in men. PLoS ONE, 9(1), e85805. https://doi.org/10.1371/journal.pone.0085805
- Vigen, R., O’Donnell, C.I., Barón, A.E., Grunwald, G.K., Maddox, T.M., Bradley, S.M., & Ho, P.M. (2013). Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA, 310(17), 1829-1836. https://doi.org/10.1001/jama.2013.280386
- Yeap, B.B., Alfonso, H., Chubb, S.A.P., Handelsman, D.J., Hankey, G.J., & Flicker, L. (2014). In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality. The Journal of Clinical Endocrinology & Metabolism, 99(1), E9-E18. https://doi.org/10.1210/jc.2013-3272